Colon Cancer - Matritech’s NMP22(R) BladderChek(R) Test Could Save Lives and Reduce Expense in Screening High Risk Populations for
Matritech’s NMP22(R) BladderChek(R) Test Could Save Lives and Reduce Expense in Screening High Risk Populations for
FinanzNachrichten - May 22 11:45 AM
Matritech ( Nachrichten ) (Amex: MZT), a leading developer and marketer of protein-based diagnostic products for the early detection of cancer, announced today that independent investigators have reported that certain tests, such as the NMP22(R) BladderChek(R) Test, could save lives and reduce expense when screening high risk populations for bladder cancer.Save to My Web
MRI Helps Spot Breast Cancer in High-Risk Women
Health Scout - May 23 2:14 PM
TUESDAY, May 23 (HealthDay News) — MRI screening for women who carry the BRCA1 and BRCA2 breast cancer susceptibility gene mutations may be cost-effective, a new study shows.Save to My Web
As Summer Heats Up, Blood Donations Drop Off
[Press Release] PR Newswire via Yahoo! Finance - May 25 10:26 AM
Memorial Day Weekend is the “unofficial” start of summer, and for many Americans this means fun and relaxation.Save to My Web
Diabetes, Heart Disease Can Herald Early GI Cancers
Medical News Today - May 25 12:04 AM
Heart disease and diabetes are among the most common conditions plaguing Americans today, and they are related to a host of other diseases. [click link for full article]Save to My Web
New Surgical Simulation Lab Gives Hands-On Experience to Improve Patient Safety
Newswise - May 25 6:20 AM
A new surgical simulation laboratory, part of the Division of Surgical Research at Cedars-Sinai Medical Center in Los Angeles, may be the first state-of-the-art simulation and training lab in California and among the first in the western United States. In addition to providing hands-on training for surgical residents and refresher opportunities for experienced surgeons, it will be used to advance Save to My Web